GoingToMeet

For any company attempting to commercialise a drug, healthy relationships with leading physicians in relevant clinical areas can be a real bonus.

But whilst locating and liaising with Key Opinion Leaders is an increasingly necessary part of your marketing strategy, it can be difficult to ensure that interactions both present value for money, and avoid conflicts of interest. And with moves towards regulation of physician-pharmaceutical industry interactions, this is currently a key topic for many in both medical practice and industry.

SMi’s Key Opinion Leaders Conference is one of the first in the EU to look at this fascinating area. With an unparalleled panel of speakers, this conference represents an excellent opportunity to come to terms with the ethical and practical issues surrounding KOLs.